Joint Committee on Vaccination and Immunisation

Health written question – answered on 14th January 2014.

Alert me about debates like this

Photo of Tony Cunningham Tony Cunningham Labour, Workington

To ask the Secretary of State for Health, with reference to the draft Joint Committee on Vaccination and Immunisation minutes of 2 October 2013, which organisation or individual advised the Joint Committee to conduct an independent review of the health economic components of the cost-effectiveness evaluation of Bexsero; and on what grounds such advice was provided.

Photo of Jane Ellison Jane Ellison The Parliamentary Under-Secretary of State for Health

The Joint Committee on Vaccination and Immunisation (JCVI) was advised to conduct an independent review of the health economic components of the cost-effectiveness evaluation of Bexsero by the meningococcal sub-committee of the JCVI following their meeting of 20 September 2013.

On 24 July 2013, JCVI published an interim statement on the use of Bexsero® in the United Kingdom. A period of consultation followed and comments were invited and received from key stakeholders. Having considered information in the stakeholder submissions, the meningococcal sub-committee advised JCVI that a review of the cost-effectiveness evaluation of Bexsero® was appropriate.

Does this answer the above question?

Yes0 people think so

No0 people think not

Would you like to ask a question like this yourself? Use our Freedom of Information site.